Johnson & Johnson to offer four prescription medicines on TrumpRx website - Reuters
Johnson & Johnson to offer four prescription medicines on TrumpRx website Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOaGtIbmpWRkJrNVh6bEg2TXlqOTVqY2pnU1FVWGFCNWVaeS1NN3dZbG5zM3RKM2RDWjVsNmRiZk50eWppT0E5VlZPdmNGN3JqVDFURTY5NWRwczdGajRRYi11Z1VBcEZ2UEtBYmlReGxOdl9HS1p5TTZtcnNGVVdLd0pVckV3SXpETHZIYTJzWE92WXZacE43Uk9EVVlZM1lVRDJyTVJyU0pYVmRxQ1BzcEhZaVFkQm9wNHpMLU5lMGRXc1VMZlZnZXNDRXpYUDg0ekpHN3c4M3o3Rzc1cUdCNHZTYVF1UXc?oc=5" target="_blank">Johnson & Johnson to offer four prescription medicines on TrumpRx website</a> <font color="#6f6f6f">Reuters</font>
Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto.
Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website, including metformin, Invokana, and Xarelto.
Johnson & Johnson will start marketing four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto.
Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website, including metformin, Invokana, and Xarelto.
Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto, as part of an agreement to reduce drug prices for Americans.
Similar Stories
Related coverage based on topic and tags
Pharma lobby sues Trump administration over Medicare drug price cuts - Reuters
Pharma lobby sues Trump administration over Medicare drug price cuts Reuters
October 7, 2026 at 05:08 PMUS states label abortion drugs a 'public nuisance' in bid to curb access - Reuters
US states label abortion drugs a 'public nuisance' in bid to curb access Reuters
October 8, 2026 at 01:24 PMUS health secretary Kennedy launches new push on vaccine injuries - Reuters
US health secretary Kennedy launches new push on vaccine injuries Reuters
October 8, 2026 at 09:59 PMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AM